Neo Pharma Private Limited
MahaRERA Property Intelligence · Mumbai Suburban
P51800003417 · Kandivali · promoter Neo Pharma Private
| MahaRERA registration | P51800003417 |
| Registered on | 05 Aug 2017 |
| Promoter-declared completion | 30 Apr 2022 |
| Current status | Certificate Signed |
| Against today | about 51 months past the declared date |
MahaRERA's own defaulter/deregistration lists and the project's quarterly-progress-report filing — the regulator's view of whether this project is in good standing.
Across MahaRERA, Neo Pharma Private is the promoter of record on 2 projects, of which none currently carry a MahaRERA regulator flag (insolvency, deregistration, completion-lapse or QPR default). Read the pattern across the portfolio, not just this project's brochure — matched on the promoter name in the MahaRERA register.
The buildings and wings registered under this project, with each tower's sanctioned height and declared completion date. Here the tallest tower rises to G+11.
| Building | Wings | Floors | Declared completion |
|---|---|---|---|
| Kalpataru Avenue | 1 | G+11 | 30 Apr 2022 |
1 complaint is on the MahaRERA record for this project, with orders passed in 1. An adjudicated complaint is the clearest evidence of how this promoter behaves when pushed — read the orders in full.
| Complaint no. | Filed | Parties | Status |
|---|---|---|---|
| CC006000000193710 | 12/08/2020 | Dr. Vidyasindhu Anantrao Sejao & Dr. Aarti V. Sejao vs Neo Pharma Private Limited | order passed |
The promoter has declared 1 court case on this project to MahaRERA. 1 is still pending. Litigation can cloud the land title or stall the build — have a lawyer pull the cause list for each and confirm whether it touches the title to your flat. This is declared by the promoter; there may be further cases not on the RERA record.
| Court | Case no. | Year | Status |
|---|---|---|---|
| Bombay High Court | 2289 | 2012 | Pending |
The promoter has had the MahaRERA completion deadline formally extended 1 time. Each extension is the regulator letting the finish line move — the clearest evidence of delivery slippage, straight from the record.
| From (declared) | To (revised) | Stated reason |
|---|---|---|
| 30 Apr 2022 | 31 Oct 2021 | We may inform that due to COVID-19, the supply chains were disrupted and also labour was not available who migrated to their home town leading to likely delay in completion of the |
Located at Kandivali, Akurli Road, Andheri, Mumbai Suburban, 400101. Per the filed land record, the plot is bounded to the north by 134 A-4 of Village Akurli, to the south by Akurli Road, to the east by Municipal Market-plot - 134-F-1A Pt of Vill Akurli and to the west by 18 mt D P Road. Confirm these against the 7/12 extract and the sanctioned plan before you rely on them.
The nearest major job hub is ~12 km away — a real but liveable commute to the nearest job hub — factor peak-hour traffic.
| Landmark | Straight-line |
|---|---|
| Andheri MIDC / SEEPZ | 12 km |
| Powai / Hiranandani business park | 15 km |
| Chhatrapati Shivaji Int'l Airport | 17 km |
| Bandra Kurla Complex (BKC) | 19 km |
| Lower Parel / Worli business district | 27 km |
| Nariman Point / Fort | 35 km |
Straight-line distances from the geocoded project locality (the RERA address is an area, not a door) — directional, not door-to-door drive times. Check the actual road route, the nearest metro station and daily-need shops/schools/hospitals on a site visit.
🔒 The verdict & buyer playbook · Compliance report
The paid report opens with the overall risk read on this MahaRERA filing, exactly what I'd do as a buyer in this project, who it suits, and the questions to put to the promoter before you commit.
🔒 Unit-by-unit guidance · Unit Guidance report
Which building/wing and unit to prefer and the sanctioned-plan read for this project — the ₹2,999 guidance layer.
🔒 Full financial records — escrow, funding & the document catalog · Compliance report
The RERA 70% designated-escrow account activity, the declared means-of-finance, the professionals of record, and every document filed with MahaRERA — the raw records the read above is built on.
Should you buy in Kalpataru Avenue?
This page is the free MahaRERA filing summary. The full RERA Property Intelligence Report gives you the full regulatory standing, declared court litigation, buyer-complaint and adjudication history, quarterly-progress-report discipline, the builder's MahaRERA-wide track record, the building/tower breakdown, and the sanctioned layout plan. See a real one first:
Sample: Lodha Kandivali – Tower 2 → · browse all sample reports →
Compliance Report · ₹999
The regulator’s filing record, read · 1 working day
Scan with any UPI app to pay · quietlist@kotak
Unit Guidance Report · ₹2,999
Everything, down to which unit · 1 working day
Not useful to your decision? Full refund — no questions asked.
Scan with any UPI app to pay · quietlist@kotak
Paying from outside India? Pay $15 (Compliance) or $39 (Unit Guidance) via PayPal, or email hello@quietlist.in for a card invoice. Prefer to talk first, or have a portfolio to check? Same address. An information aid for your own due diligence, not legal or investment advice.
Free · Watch this project
We'll email you when this project's RERA record changes.
Neo Pharma Private Limited is the promoter on 2 MahaRERA-registered projects, with none currently carrying a regulator flag — a reassuring wider track record (matched on the promoter name in the register; it doesn't guarantee this specific project, but a clean portfolio is a good sign).
Flags are from MahaRERA's own published problem lists — not a claim about the developer's intent. Explore every flagged project on our Mumbai, Thane & the MMR RERA red-flag register.
Last checked against the RERA register: 27 Jul 2026